This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Lo, A. C Articles by Vollmer, T. L Search for Related Content PubMed PubMed Citation Articles by Lo, A. C Articles by Vollmer, T. L Social Bookmarking                         What's this?

Treatment patterns of multiple sclerosis patients: a comparison of veterans and non-veterans using the NARCOMS registry

Department of Neurology, Yale School of Medicine and VA Connecticut Healthcare System, West Haven, CT, USA, albert.lo{at}yale.edu

Olympia Hadjimichael

Department of Neurology, Yale School of Medicine and VA Connecticut Healthcare System, West Haven, CT, USA

Timothy L Vollmer

Barrow Neurological Institute, Phoenix, AZ, USA

Multiple sclerosis (MS) is a chronic illness of the central nervous system, with a highly variable clinical course. Available therapies are only partially effective and as a consequence treatment patterns between patients can be varied. Longitudinal databases consisting of large cohorts where successive and sequential data is collected may reveal disease and treatment characteristics not apparent when data is gathered during clinical trials that consist usually of relatively homogeneous patients followed for short durations. We analysed data from the North American Research Committee on Multiple Sclerosis registry, a self-reported database, to assess MS patient characteristics and treatment patterns, with a focus on veterans. We show that the Veteran Healthcare Administration (VHA) system of medical centres care for a greater number of patients with higher average disability but not necessarily patients who report primary progressive or actively worsening disease. We also show that the VHA medical centres appear to better provide multidisciplinary care, particularly in the areas of social work, physical therapy and urology. In general, treatment patterns for symptomatic therapies follow similar patterns across veterans and non-veterans groups. Treatment patterns for immunomodulatory agents suggest that VHA veterans use IMA less frequently than either non-VHA veterans or non-veterans.

Key Words: databases • disease-modifying agents • healthcare delivery • multiple sclerosis • symptomatic treatment

Multiple Sclerosis, Vol. 11, No. 1, 33-40 (2005)
DOI: 10.1191/1352458505ms1136oa


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				S Minden, D Hoaglin, S Jureidini, L Hadden, D Frankel, Y Komatsuzaki, and J Outley Disease-modifying agents in the Sonya Slifka Longitudinal Multiple Sclerosis Study Multiple Sclerosis, June 1, 2008; 14(5): 640 - 655. [Abstract] [PDF]